Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 9Recruiting 2Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 4Ovarian Neoplasms 2Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Sedation 1Recurrence 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Liver Neoplasms 1Intraoral Tumor 1Hypoxia 1Esophageal Neoplasms 1Emergence Delirium 1Disease Progression 1Delirium 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 38Blood Specimen Collection 38Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 17Exercise 17Carboplatin 17Nivolumab 15atezolizumab 14Paclitaxel 14Cisplatin 14Drug Therapy 13Fluorouracil 12Cyclophosphamide 12Cetuximab 11Trastuzumab 10Pemetrexed 10Leucovorin 10Docetaxel 10Dexamethasone 10Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Propofol × Clear all
NCT04800393 2023-04-26

TeMP

Moscow Clinical Scientific Center

Phase NA Recruiting
130 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Hong Kong Children's Hospital

Phase 4 Recruiting
100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡